American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3
Jeffrey R. Curtis(University of Alabama at Birmingham Hospital), Ted R. Mikuls(Nebraska Medical Center), Ellen M. Gravallese(Brigham and Women's Hospital), Donald D. Anthony(MetroHealth), Sindhu R. Johnson(Toronto Western Hospital), Anne R. Bass(Hospital for Special Surgery), Andrew T. Kroger(CDC Foundation), Rebecca E. Sadun(Duke University), Amy S. Turner(American College of Rheumatology), Rafael Harpaz(Herman Miller (United States)), Eleanor Anderson Williams(Colorado Permanente Medical Group), Lindsey R. Baden(Brigham and Women's Hospital), Reuben J. Arasaratnam(Southwestern Medical Center), Cassandra Calabrese(Cleveland Clinic)
Cited by 201
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k